ZA200805079B - Immunostimulatory compositions and methods - Google Patents
Immunostimulatory compositions and methodsInfo
- Publication number
- ZA200805079B ZA200805079B ZA200805079A ZA200805079A ZA200805079B ZA 200805079 B ZA200805079 B ZA 200805079B ZA 200805079 A ZA200805079 A ZA 200805079A ZA 200805079 A ZA200805079 A ZA 200805079A ZA 200805079 B ZA200805079 B ZA 200805079B
- Authority
- ZA
- South Africa
- Prior art keywords
- methods
- immunostimulatory compositions
- immunostimulatory
- compositions
- Prior art date
Links
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US74817705P | 2005-12-08 | 2005-12-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200805079B true ZA200805079B (en) | 2009-08-26 |
Family
ID=40421927
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200805079A ZA200805079B (en) | 2005-12-08 | 2006-12-07 | Immunostimulatory compositions and methods |
ZA200805081A ZA200805081B (en) | 2005-12-08 | 2008-01-01 | In vivo cell surface engineering |
ZA200805080A ZA200805080B (en) | 2005-12-08 | 2008-06-09 | Methods and compositions for expanding T regulatory cells |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200805081A ZA200805081B (en) | 2005-12-08 | 2008-01-01 | In vivo cell surface engineering |
ZA200805080A ZA200805080B (en) | 2005-12-08 | 2008-06-09 | Methods and compositions for expanding T regulatory cells |
Country Status (2)
Country | Link |
---|---|
CN (3) | CN101378783A (en) |
ZA (3) | ZA200805079B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2760997C2 (en) * | 2016-01-14 | 2021-12-02 | Интрексон Актобиотикс Н.В. | Compositions and methods for treating type 1 diabetes |
SG10201912046VA (en) * | 2016-02-26 | 2020-02-27 | Scm Lifescience Co Ltd | Pharmaceutical composition for preventing or treating regulatory t cell-mediated diseases |
CN106632684A (en) * | 2016-06-01 | 2017-05-10 | 上海领潮生物科技有限公司 | Fusion protein used for rapidly detecting type I diabetes |
CN107082812B (en) | 2017-03-29 | 2018-11-13 | 上海科医联创生物科技有限公司 | It is a kind of restore debilitating immune cell function fusion protein and its application |
CN109468337A (en) * | 2017-09-08 | 2019-03-15 | 广州市丹蓝生物科技有限公司 | Recombinant dna fragment and its application, the antigen and its production method of diagnosing autoimmune diseases |
US20200299639A1 (en) * | 2017-09-15 | 2020-09-24 | Life Technologies Corporation | Compositions and methods for culturing and expanding cells |
MX2022006000A (en) * | 2019-11-20 | 2022-06-17 | Gi Cell Inc | Composition for culturing regulatory t cells and use thereof. |
-
2006
- 2006-12-07 CN CNA2006800524903A patent/CN101378783A/en active Pending
- 2006-12-07 CN CNA2006800525111A patent/CN101426532A/en active Pending
- 2006-12-07 ZA ZA200805079A patent/ZA200805079B/en unknown
- 2006-12-07 CN CNA2006800525516A patent/CN101426533A/en active Pending
-
2008
- 2008-01-01 ZA ZA200805081A patent/ZA200805081B/en unknown
- 2008-06-09 ZA ZA200805080A patent/ZA200805080B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101426532A (en) | 2009-05-06 |
CN101378783A (en) | 2009-03-04 |
ZA200805081B (en) | 2009-08-26 |
ZA200805080B (en) | 2009-08-26 |
CN101426533A (en) | 2009-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1895838A4 (en) | Compositions and methods | |
EP1874345A4 (en) | Immunostimulatory compositions | |
GB0522287D0 (en) | Method and compositions | |
EP1940423A4 (en) | Tissue engineering methods and compositions | |
EP1819364A4 (en) | Immunomodulatory compositions, combinations and methods | |
IL190259A0 (en) | Compositions and methods comprising panax species | |
IL192098A (en) | Compositions and methods for producing them | |
EP1819226A4 (en) | Immunostimulatory combinations and methods | |
PL1940240T3 (en) | Protein isolate compositions and uses thereof | |
IL187617A0 (en) | Lkktet and/or lkktnt peptide compositions and methods | |
EP1968526A4 (en) | Foamable dental compositions and methods | |
IL191072A0 (en) | Therapeutic compositions and methods | |
EP2101731A4 (en) | Endoxifen methods and compositions | |
EP1962852A4 (en) | Compounds, compositions and methods | |
EP1991237A4 (en) | Chemoprotective methods and compositions | |
SI1814977T1 (en) | Arthrospira-based compositions and uses thereof | |
EP1778219A4 (en) | Ascophyllum compositions and methods | |
EP1773386A4 (en) | Vaccine compositions and methods | |
EP1848438A4 (en) | Diaminophenothiazine compositions and uses thereof | |
EP2088865A4 (en) | Guggulphospholipid methods and compositions | |
GB0617171D0 (en) | Novel compositions and methods | |
ZA200608935B (en) | Methods and compositions for epilation | |
ZA200805079B (en) | Immunostimulatory compositions and methods | |
ZA200803748B (en) | Nematicidal compositions and methods | |
GB0524927D0 (en) | Compositions and method |